Johnson & Johnson's COVID-19 Vaccine Under Review At EMA For Blood Clots, AstraZeneca Probe Expanded
AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine has recently dominated headlines after cases of rare blood clots were...
15M Doses Of JNJ COVID-19 Vaccine Batch Ruined After Ingredient Issues At Emergent Biosolutions' US Plant: NYT
One batch of Johnson & Johnson’s (NYSE: JNJ) COVID-19 vaccines read more
New York Times Credits Report On Emergent BioSolutions For Biden's Canceled Vaccine Plant Visit
The New York Times (NYSE: NYT) is crediting its reporting for President Joe Biden’s decision...
